Evidence map›Paper›PMID 25200414›Full record

ArticleDrugs & aging2014

Adverse drug reactions in elderly subjects hospitalized in a specialized dementia management unit.

Lukshe Kanagaratnam, Rachid Mahmoudi, Jean-Luc Novella, Damien Jolly, Moustapha Dramé, Thierry Trenque

Abstract read
PubMed Publisher
In one paragraph

Article in Drugs & aging, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 26 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Lukshe KanagaratnamDepartment of Pharmacovigilance and Pharmacoepidemiology, Reims University Hospitals, Reims, France.
Rachid Mahmoudi
Jean-Luc Novella
Damien Jolly
Moustapha Dramé
Thierry Trenque
Centre Hospitalier Universitaire de Reims · FRUniversité de Reims Champagne-Ardenne · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionDrug prescriptions represent an actionable item in the prevention of adverse drug reactions (ADRs). The aims of this study were to identify risk factors for the occurrence of ADRs, and to describe symptoms and drug interactions.

methodsThis was a longitudinal study over a period of 19 months in an acute geriatric ward specializing in the management of dementia. Independent risk factors for ADRs were identified by logistic regression. Drug interactions were also recorded.

resultsIn total, 293 patients were included (age 82 ± 8 years). The prevalence of ADRs was 24 %. Patients were taking 8 ± 3 drugs per day; 72 (24.6 %) were taking more than three psychotropics. The main therapeutic classes prescribed were anxiolytics and hypnotics (57.7 %), antidementia drugs (54.6 %), antidepressants (54.3 %), antithrombotics (54.0 %), angiotensin-converting enzyme inhibitors [ACEIs] or angiotensin II receptor blockers [ARBs] (37.5 %). The risk of ADRs was significantly higher in patients taking neuroleptics (odds ratio [OR] 2.04; 95 % confidence interval [CI] 1.06-3.92), ACEIs/ARBs (OR 2.07; 95 % CI 1.13-3.77) and antidementia drugs (OR 1.84; 95 % CI 1.01-3.36). The risk of serious ADRs was significantly higher in patients taking ACEIs/ARBs (OR 2.95; 95 % CI 1.40-6.21), type I, III or IV antiarrhythmics (OR 2.71; 95 % CI 1.07-6.88) or neuroleptics (OR 2.42; 95 % CI 1.09-5.40). Drug interactions were involved in 26.3 % (n = 21) of ADRs; the combination of an ADR plus a drug interaction was associated with increased severity (p = 0.02).

conclusionCaution is needed when prescribing ACEIs/ARBs, neuroleptics, antidementia drugs, or certain types of antiarrhythmics in patients suffering from dementia. Psychotropics should be avoided because of the associated risk of ADRs and drug interactions.

Indexed as

AgingAged, 80 and overAngiotensin-Converting Enzyme InhibitorsAntidepressive AgentsDementiaDrug InteractionsDrug-Related Side Effects and Adverse ReactionsFemaleFranceHealth Services for the AgedHospitalizationHumansHypnotics and SedativesLongitudinal StudiesLong-Term CareMaleAngiotensin-Converting Enzyme InhibitorsAntidepressive AgentsHypnotics and Sedatives

Identifiers

PMID25200414
OpenAlexW1980285208

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.